Pricing Availability Delivery Time Qty
Cat.No. 0321 - (RS)-4-Carboxyphenylglycine | C9H9NO4 | CAS No. 7292-81-1
Description: Broad spectrum EAA ligand
Alternative Names: (RS)-4CPG
Purity: ≥99% (HPLC)
Citations (2)

Biological Activity

Broad spectrum EAA ligand.

S-enantiomer and R-enantiomer also available.

Technical Data

M. Wt 195.17
Formula C9H9NO4
Storage Store at RT
Purity ≥99% (HPLC)
CAS Number 7292-81-1
PubChem ID 5115
Smiles NC(C(O)=O)C1=CC=C(C(O)=O)C=C1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

All Tocris products are intended for laboratory research use only.

Solubility Data

SolubilitySoluble to 100 mM in 1eq. NaOH and to 5 mM in water

Preparing Stock Solutions

The following data is based on the product molecular weight 195.17. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 5.12 mL 25.62 mL 51.24 mL
5 mM 1.02 mL 5.12 mL 10.25 mL
10 mM 0.51 mL 2.56 mL 5.12 mL
50 mM 0.1 mL 0.51 mL 1.02 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Product Datasheets

Safety Datasheet


References are publications that support the products' biological activity.

If you know of a relevant reference for (RS)-4-Carboxyphenylglycine, please let us know.

View Related Products by Product Action

View all Non-selective Ionotropic Glutamate Ligands

Keywords: (RS)-4-Carboxyphenylglycine, supplier, Broad, spectrum, EAA, ligand, Glutamate, Ionotropic, Non-Selective, iGluR, Receptors, mGlur, Metabotropic, (RS)-4CPG, Non-selective, Ionotropic, Glutamate, Non-selective, mGlu, Non-selective, Ionotropic, Glutamate, Tocris Bioscience

2 Citations for (RS)-4-Carboxyphenylglycine

Citations are publications that use Tocris products. Selected citations for (RS)-4-Carboxyphenylglycine include:

Singh et al (2006) Altered balance of glutamatergic/GABAergic synaptic input and associated changes in dendrite morphology after BDNF expression in BDNF-deficient hippocampal neurons. Addict Biol 26 7189 PMID: 16822976

Yokoi et al (1995) Refinement of odor molecule tuning by dendrodendritic synaptic inhibition in the olfactory bulb. J Neurosci 92 3371 PMID: 7724568

Do you know of a great paper that uses (RS)-4-Carboxyphenylglycine from Tocris? If so please let us know.

Reviews for (RS)-4-Carboxyphenylglycine

There are currently no reviews for this product. Be the first to review (RS)-4-Carboxyphenylglycine and earn rewards!

Have you used (RS)-4-Carboxyphenylglycine?

Submit a review and receive an Amazon gift card.

$10US/$10CAN/€7/£6 gift card for a review without an image

$25US/$25CAN/€18/£15 gift card for a review with an image

*Offer only valid in the USA / Canada, UK and Europe

Submit a Review

Literature in this Area


Pain Research Product Guide

A collection of over 250 products for pain research, the guide includes research tools for the study of:

  • Nociception
  • Ion Channels
  • G-Protein-Coupled Receptors
  • Intracellular Signaling

Pain Poster

Peripheral sensitization is the reduction in the threshold of excitability of sensory neurons that results in an augmented response to a given external stimulus. This poster outlines the excitatory and inhibitory signaling pathways involved in modulation of peripheral sensitization. The role of ion channels, GPCRs, neurotrophins, and cytokines in sensory neurons are also described.


Parkinson's Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.